<?xml version='1.0' encoding='utf-8'?>
<document id="24858839"><sentence text="Coadministration of co-trimoxazole with sulfonylureas: hypoglycemia events and pattern of use."><entity charOffset="20-34" id="DDI-PubMed.24858839.s1.e0" text="co-trimoxazole" /><entity charOffset="40-53" id="DDI-PubMed.24858839.s1.e1" text="sulfonylureas" /><pair ddi="false" e1="DDI-PubMed.24858839.s1.e0" e2="DDI-PubMed.24858839.s1.e0" /><pair ddi="false" e1="DDI-PubMed.24858839.s1.e0" e2="DDI-PubMed.24858839.s1.e1" /></sentence><sentence text="Coadministration of co-trimoxazole with sulfonylureas is reported to increase the risk of hypoglycemia"><entity charOffset="20-34" id="DDI-PubMed.24858839.s2.e0" text="co-trimoxazole" /><entity charOffset="40-53" id="DDI-PubMed.24858839.s2.e1" text="sulfonylureas" /><pair ddi="false" e1="DDI-PubMed.24858839.s2.e0" e2="DDI-PubMed.24858839.s2.e0" /><pair ddi="false" e1="DDI-PubMed.24858839.s2.e0" e2="DDI-PubMed.24858839.s2.e1" /></sentence><sentence text="" /><sentence text="We identified a cohort of Medicare beneficiaries aged 66 years or older who took glyburide or glipizide for diabetes from a 5% national sample of Medicare Part D claims data in 2008 (n = 34,239)"><entity charOffset="81-90" id="DDI-PubMed.24858839.s4.e0" text="glyburide" /><entity charOffset="94-103" id="DDI-PubMed.24858839.s4.e1" text="glipizide" /><pair ddi="false" e1="DDI-PubMed.24858839.s4.e0" e2="DDI-PubMed.24858839.s4.e0" /><pair ddi="false" e1="DDI-PubMed.24858839.s4.e0" e2="DDI-PubMed.24858839.s4.e1" /></sentence><sentence text=" We tracked each participant's claims during 2008-2010 for a co-trimoxazole prescription and subsequent emergency room visits for hypoglycemia"><entity charOffset="61-75" id="DDI-PubMed.24858839.s5.e0" text="co-trimoxazole" /></sentence><sentence text=" Descriptive statistics and logistic regression modeling were used to evaluate hypoglycemia-related emergency room visits after coadministration of co-trimoxazole with sulfonylureas and its utilization patterns in older adults with diabetes"><entity charOffset="148-162" id="DDI-PubMed.24858839.s6.e0" text="co-trimoxazole" /><entity charOffset="168-181" id="DDI-PubMed.24858839.s6.e1" text="sulfonylureas" /><pair ddi="false" e1="DDI-PubMed.24858839.s6.e0" e2="DDI-PubMed.24858839.s6.e0" /><pair ddi="false" e1="DDI-PubMed.24858839.s6.e0" e2="DDI-PubMed.24858839.s6.e1" /></sentence><sentence text="" /><sentence text="Sulfonylureas users prescribed co-trimoxazole had a significant higher risk of emergency room visits for hypoglycemia, compared with those prescribed noninteracting antibiotics (odds ratio = 3"><entity charOffset="0-13" id="DDI-PubMed.24858839.s8.e0" text="Sulfonylureas" /></sentence><sentence text="89, 95% confidence interval = 2" /><sentence text="29-6" /><sentence text="60 for glipizide and odds ratio = 3"><entity charOffset="7-16" id="DDI-PubMed.24858839.s11.e0" text="glipizide" /></sentence><sentence text="78, 95% confidence interval = 1" /><sentence text="81-7" /><sentence text="90 for glyburide with co-trimoxazole, using amoxicillin as the reference)"><entity charOffset="7-16" id="DDI-PubMed.24858839.s14.e0" text="glyburide" /><entity charOffset="44-55" id="DDI-PubMed.24858839.s14.e1" text="amoxicillin" /><pair ddi="false" e1="DDI-PubMed.24858839.s14.e0" e2="DDI-PubMed.24858839.s14.e0" /><pair ddi="false" e1="DDI-PubMed.24858839.s14.e0" e2="DDI-PubMed.24858839.s14.e1" /></sentence><sentence text=" Co-trimoxazole was prescribed to 16"><entity charOffset="1-15" id="DDI-PubMed.24858839.s15.e0" text="Co-trimoxazole" /></sentence><sentence text="9% of those taking glyburide or glipizide during 2008-2010, varying from 4"><entity charOffset="19-28" id="DDI-PubMed.24858839.s16.e0" text="glyburide" /><entity charOffset="32-41" id="DDI-PubMed.24858839.s16.e1" text="glipizide" /><pair ddi="false" e1="DDI-PubMed.24858839.s16.e0" e2="DDI-PubMed.24858839.s16.e0" /><pair ddi="false" e1="DDI-PubMed.24858839.s16.e0" e2="DDI-PubMed.24858839.s16.e1" /></sentence><sentence text="0% to 35" /><sentence text="9% across U" /><sentence text="S" /><sentence text=" hospital referral regions" /><sentence text=" Patients with polypharmacy and with more prescribers were more likely to receive co-trimoxazole"><entity charOffset="82-96" id="DDI-PubMed.24858839.s21.e0" text="co-trimoxazole" /></sentence><sentence text=" Patients with an identifiable primary care physician had 20% lower odds of receiving a co-trimoxazole prescription"><entity charOffset="88-102" id="DDI-PubMed.24858839.s22.e0" text="co-trimoxazole" /></sentence><sentence text=" Hospital referral regions with more PCPs had lower rates of coadministration of the two drugs (r = -" /><sentence text="26, p &lt; 0" /><sentence text="001)" /><sentence text="" /><sentence text="Coadministration of co-trimoxazole with sulfonylureas is associated with increased risk of hypoglycemia, compared with noninteracting antibiotics"><entity charOffset="20-34" id="DDI-PubMed.24858839.s27.e0" text="co-trimoxazole" /><entity charOffset="40-53" id="DDI-PubMed.24858839.s27.e1" text="sulfonylureas" /><pair ddi="false" e1="DDI-PubMed.24858839.s27.e0" e2="DDI-PubMed.24858839.s27.e0" /><pair ddi="false" e1="DDI-PubMed.24858839.s27.e0" e2="DDI-PubMed.24858839.s27.e1" /></sentence><sentence text=" Such coadministration is prevalent among older diabetic patients in the United States, especially in patients without an identifiable primary care physician" /><sentence text="" /></document>